Mad2L2/REV7 antibody | knockout validation | Abcam ab180579

This is a knockout-validated antibody summary, based on the publication "53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rabbit monoclonal IgG

Company: Abcam

Antibody: Mad2L2/REV7

Catalog number: ab180579

Summary: Rabbit monoclonal IgG against a synthetic peptide within human Mad2L2/REV7(aa 150 to the C-terminus). Reacts with mouse, rat and human. Suitable for western blot, immunoprecipitation, immunocytochemistry/immunofluorescence, immunohistochemistry (paraffin) and flow cytometry.

Validation Method

Western blot

Sample

Control and Rev7-KO MEF cells.

Figure

Immunoblots showing loss of Rev7 and Stn1 in the indicated TPP1F/F Rev7+/+ MEFs and TPP1F/F Rev7−/− (CRISPR) clones treated with Cre (96 h) and/or Stn1 shRNA as indicated. Please see Figure 1b in the article [1].

References
  1. Mirman Z, Lottersberger F, Takai H, Kibe T, Gong Y, Takai K, et al. 53BP1-RIF1-shieldin counteracts DSB resection through CST- and Polα-dependent fill-in. Nature. 2018;560:112-116 pubmed publisher